MYOLARIS
Live / Applied — Fourth extension granted (statement of use) (as of 16 May 2025)
What this means for you
Not registered yet, but its 12 May 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97408309
- Mark type
- Stylized text
- Filed
- 12 May 2022
- Published for opposition
- 25 Apr 2023
- Attorney of record
- Alex P. Garens
Goods and services
- Class 010 — Medical apparatus: Medical diagnostic solutions and platforms for medical and research purposes, namely, medical apparatus for testing the presence of biomarkers relevant for treatment responsiveness and drug efficacy
- Class 042 — Scientific and technological services: Providing medical and scientific testing information services for medical and scientific research purposes, namely, reporting test results and analysis of customers tests; computer aided biomarker discovery services for identifying potential biomarkers for use in researching disease, diagnosis of disease, drug compound safety, drug efficacy, treatment efficacy, therapy responsiveness, and drug side-effects; providing scientific analysis and informational reports based upon results of laboratory testing in the field of diagnostics and biomarkers; providing online computer databases featuring scientific information based on aggregated results of biomarker testing; application service provider (ASP) featuring software for providing access to multiple databases that contain aggregated results of biomarker testing; application service provider (ASP) featuring software for use in data management, data storage, data analysis, report generation, user identification, and membership identification, all in the fields of diagnostics and biomarkers; application service provider featuring application programming interface (API) software for connectivity with third party clinical health databases and platforms; software as a service (SAAS) services featuring software for providing access to multiple databases that contain aggregated results of biomarker testing; software as a service (SAAS) services featuring software for use in data management, data storage, data analysis, report generation, user identification, and membership identification, all in the fields of diagnostics and biomarkers
Owner
- Olaris, Inc., Framingham, MA, US
- Olaris, Inc., Framingham, MA, US
Prior registrations
Prosecution history
- 08 Dec 2025 — TEAS STATEMENT OF USE RECEIVED
- 08 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 17 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 May 2025 — SOU EXTENSION 4 GRANTED
- 16 May 2025 — SOU EXTENSION 4 FILED
- 16 May 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Dec 2024 — SOU EXTENSION 3 GRANTED
- 13 Dec 2024 — SOU EXTENSION 3 FILED
- 13 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 23 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 May 2024 — SOU EXTENSION 2 GRANTED
- 22 May 2024 — SOU EXTENSION 2 FILED
- 22 May 2024 — SOU TEAS EXTENSION RECEIVED
- 10 Nov 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED